DMD and Duchenne muscular dystrophy: Despite positive outcomes in terms of dystrophin expression in early transplantation studies in mdx mice [10–13], no improvement was reported in DMD patients enrolled in early phase clinical trials [16–19], which was overall attributed to limited survival and migratory capacity of injected cells [13, 18, 20].